Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Prostate Cancer treatment details. Chemotherapy. St Bartholomew's Hospital, London, United Kingdom

Survival: 7.7 months
Toxicity Grade:
Treatments: Chemotherapy
Country: United Kingdom
City/State/Province: London
Hospital: St Bartholomew's Hospital
Journal: Link
Date: 1/2008

Patients: This phase II study involved 43 men with androgen-independent prostate cancer. They ranged in age from 50 to 86 years old. The median age was 72.

Treatment: After undergoing initial chemotherapy and endocrine therapy, patients were given another endocrine-targeted therapy. Specifically, patients were treated with the chemotherapy drugs chlorambucil, lomustine, and etoposide. When their disease progressed, they were treated with endocrine therapy, the hormones bicalutamide and GnRH analogue. After this treatment ‘failed’ they were treated with the hormone diethylstilbestrol and the anti-inflammatory drug dexamethasone.

Toxicity: No information reported

Results: The median overall survival was 7.7 months, from the time of starting the second round of endocrine therapy.

Correspondence: Dr. Jonathan Shamash

E-mail to a Friend Email Physician More Information